nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0305	0.0305	CbGpPWpGaD
Bopindolol—HTR1B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0276	0.0276	CbGpPWpGaD
Bopindolol—ADRB3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.026	0.026	CbGpPWpGaD
Bopindolol—ADRB3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0253	0.0253	CbGpPWpGaD
Bopindolol—ADRB3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0236	0.0236	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0228	0.0228	CbGpPWpGaD
Bopindolol—ADRB3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0219	0.0219	CbGpPWpGaD
Bopindolol—ADRB3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0213	0.0213	CbGpPWpGaD
Bopindolol—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.021	0.021	CbGpPWpGaD
Bopindolol—ADRB3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0198	0.0198	CbGpPWpGaD
Bopindolol—HTR1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0194	0.0194	CbGpPWpGaD
Bopindolol—HTR1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0188	0.0188	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0181	0.0181	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0177	0.0177	CbGpPWpGaD
Bopindolol—HTR1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0176	0.0176	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0173	0.0173	CbGpPWpGaD
Bopindolol—ADRB3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0165	0.0165	CbGpPWpGaD
Bopindolol—HTR1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0163	0.0163	CbGpPWpGaD
Bopindolol—HTR1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0158	0.0158	CbGpPWpGaD
Bopindolol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0155	0.0155	CbGpPWpGaD
Bopindolol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0151	0.0151	CbGpPWpGaD
Bopindolol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.015	0.015	CbGpPWpGaD
Bopindolol—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0148	0.0148	CbGpPWpGaD
Bopindolol—HTR1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0148	0.0148	CbGpPWpGaD
Bopindolol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0147	0.0147	CbGpPWpGaD
Bopindolol—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0144	0.0144	CbGpPWpGaD
Bopindolol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.014	0.014	CbGpPWpGaD
Bopindolol—ADRB3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0139	0.0139	CbGpPWpGaD
Bopindolol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0137	0.0137	CbGpPWpGaD
Bopindolol—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0134	0.0134	CbGpPWpGaD
Bopindolol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.013	0.013	CbGpPWpGaD
Bopindolol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0127	0.0127	CbGpPWpGaD
Bopindolol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0126	0.0126	CbGpPWpGaD
Bopindolol—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0124	0.0124	CbGpPWpGaD
Bopindolol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0123	0.0123	CbGpPWpGaD
Bopindolol—HTR1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0123	0.0123	CbGpPWpGaD
Bopindolol—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0121	0.0121	CbGpPWpGaD
Bopindolol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0118	0.0118	CbGpPWpGaD
Bopindolol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0115	0.0115	CbGpPWpGaD
Bopindolol—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0112	0.0112	CbGpPWpGaD
Bopindolol—HTR1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0103	0.0103	CbGpPWpGaD
Bopindolol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00979	0.00979	CbGpPWpGaD
Bopindolol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00958	0.00958	CbGpPWpGaD
Bopindolol—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00936	0.00936	CbGpPWpGaD
Bopindolol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00823	0.00823	CbGpPWpGaD
Bopindolol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.00814	0.00814	CbGpPWpGaD
Bopindolol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00805	0.00805	CbGpPWpGaD
Bopindolol—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00787	0.00787	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00672	0.00672	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00652	0.00652	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00503	0.00503	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00488	0.00488	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00454	0.00454	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00431	0.00431	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00425	0.00425	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00418	0.00418	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00404	0.00404	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00392	0.00392	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00389	0.00389	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00375	0.00375	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00365	0.00365	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00364	0.00364	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00339	0.00339	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00328	0.00328	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00321	0.00321	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00318	0.00318	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00318	0.00318	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00312	0.00312	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00307	0.00307	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00298	0.00298	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00298	0.00298	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00297	0.00297	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00292	0.00292	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0029	0.0029	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0029	0.0029	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00285	0.00285	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00283	0.00283	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00278	0.00278	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00277	0.00277	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00273	0.00273	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.0027	0.0027	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0027	0.0027	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00264	0.00264	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00258	0.00258	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00256	0.00256	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0025	0.0025	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00248	0.00248	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00244	0.00244	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00244	0.00244	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00243	0.00243	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00237	0.00237	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00237	0.00237	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00237	0.00237	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00231	0.00231	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00226	0.00226	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00221	0.00221	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00221	0.00221	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00208	0.00208	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00203	0.00203	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00195	0.00195	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0019	0.0019	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00189	0.00189	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00189	0.00189	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00186	0.00186	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00185	0.00185	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00185	0.00185	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00185	0.00185	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00181	0.00181	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00181	0.00181	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0018	0.0018	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00176	0.00176	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00172	0.00172	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00168	0.00168	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00168	0.00168	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00168	0.00168	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00163	0.00163	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00162	0.00162	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00158	0.00158	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00155	0.00155	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00155	0.00155	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00152	0.00152	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00138	0.00138	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00134	0.00134	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00125	0.00125	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00125	0.00125	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00123	0.00123	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00122	0.00122	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00121	0.00121	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00118	0.00118	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00117	0.00117	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00113	0.00113	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0011	0.0011	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00108	0.00108	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00107	0.00107	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00107	0.00107	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00105	0.00105	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00104	0.00104	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00102	0.00102	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000999	0.000999	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000995	0.000995	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000994	0.000994	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000977	0.000977	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000973	0.000973	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00097	0.00097	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000965	0.000965	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000955	0.000955	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000951	0.000951	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000948	0.000948	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000927	0.000927	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000903	0.000903	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000899	0.000899	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000884	0.000884	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000875	0.000875	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000864	0.000864	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000794	0.000794	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000741	0.000741	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000719	0.000719	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000697	0.000697	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000681	0.000681	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00067	0.00067	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000666	0.000666	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000633	0.000633	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00063	0.00063	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000619	0.000619	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000605	0.000605	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00059	0.00059	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000577	0.000577	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000573	0.000573	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000564	0.000564	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00056	0.00056	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000548	0.000548	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000534	0.000534	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000522	0.000522	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00051	0.00051	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000469	0.000469	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000374	0.000374	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000366	0.000366	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000357	0.000357	CbGpPWpGaD
